Suziki
Quit while your ahead Bud. You have no idea what you are talking about. The Company has not even started the US pivotal trial. They haven’t even agreed on the design. The small IDE run in trial was for 10 patients only in the US. There will be a much larger US pivotal study, most likely in 2020 to commence. It will take several years to complete before they even get close to FDA approval and will likely cost millions. That’s right millions of dollars to run the US pivotal study.
Your pretty quick to pontificate to everyone else about investing in biotech companies but would appear to have very little understanding of what is actually going on here at Oncosil.
Anyone Left?, page-59
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.78M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $116.5K | 16.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 12312335 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3137908 | 9 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |